olivlawolivlaw

olivLaw · European equity research

Aegon Ltd. AGN.AS

Netherlands · Euronext Amsterdam · Vertical: Listed companies from Netherlands

7.63EUR+0.13% · 1 dayClose 05 Nov 2026

Aegon Ltd. is an international group in life insurance, retirement and asset management, with its main operations in the United States through Transamerica. The company is moving its head office and legal seat to the US and aims to become a leading US life insurance and retirement group, which makes its profile relevant during this transition. Operating result for 2025 was EUR 1.7 billion.

At the close of 05 Nov 2026, Aegon Ltd. (AGN.AS) stock was 7.63 EUR (+0.13% on the day), with beta 0.91, 52-week range 5.96–8.29 EUR.

Data as of · AI analysis dated · Source: ESEF annual reports and closing prices, computed by olivLaw.

Market cap
unavailable
P/E (TTM)
unavailable
E/P (TTM)
unavailable
Dividend yield
unavailable
Beta (2y)
0.91
Volatility (1y) 23%
52-week range
5.968.29

Price history

Loading chart…

Technical reading

RSI (14)
56.1
strong (55–70)
Bollinger (20, 2)
7.29 – 7.62
above the upper band · %B 1.05 · band width 4.4%
SMA 50 / 200
7.67 / 7.26
mixed trend
MACD (12, 26, 9)
-0.04 / -0.07
MACD above signal

Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).

Performance

CompanyEURO STOXX 50vs EURO STOXX 50Vertical median
1 month−0.0%+0.4%−0.4 pp—
3 months−7.6%−3.3%−4.3 pp—
6 months+7.5%+4.0%+3.5 pp—
Year to date+14.9%+8.1%+6.8 pp—
1 year+15.7%+10.7%+5.0 pp+0.3%
3 years+60.9%+50.1%+10.8 pp+2.2%
5 years+76.2%+43.6%+32.6 pp—
Max drawdown (1y)
−14.3%
27 Nov 2025 → 20 Mar 2026
Max drawdown (5y)
−30.3%
08 Feb 2022 → 07 Mar 2022
Compound annual growth (5y)
+12.0%
EURO STOXX 50 +7.5%

Price returns, dividends excluded.

Quarterly results

ESEF annual reports carry no quarters: the results are annual (below).

E/P over time

EPS unavailable in the issuer's structured filings (e.g. a partnership reports per unit, not per share).

E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.

Fiscal years

Fiscal year2022202320242025
Revenueunavailableunavailableunavailableunavailable
Revenue YoYunavailableunavailableunavailableunavailable
Net income-1.0 bn-179.0 m688.0 m977.0 m
Net income YoYunavailableunavailableunavailable+42.0%
Diluted EPSunavailableunavailableunavailableunavailable
Diluted EPS YoYunavailableunavailableunavailableunavailable
net %unavailableunavailableunavailableunavailable
Free cash flow2.6 bn799.0 m711.0 m393.0 m

Balance sheet & financial health

Fiscal year 2025 · 31 Dec 2025

Cash
2.7 bn EUR
Financial debt
unavailable EUR
Net debt
unavailable EUR
Equity
9.5 bn EUR
Total assets
317.2 bn EUR
Debt / equity
unavailable
Current ratio
unavailable
ROE
10.4%
ROA
0.3%
FCF margin
unavailable

Financial statements (source on every figure)

Revenue and net income (EUR)

Income statement · EUR

Pre-tax income
2023
-391.0 m
2024
660.0 m
2025
1.0 bn

esef· 07 Apr 2026verified

Income tax
2023
-209.0 m
2024
-16.0 m
2025
65.0 m

esef· 07 Apr 2026verified

Net income
2023
-179.0 m
2024
688.0 m
2025
977.0 m

esef· 07 Apr 2026verified

Balance sheet · EUR

Cash
2023
4.1 bn
2024
3.5 bn
2025
2.7 bn

esef· 07 Apr 2026verified

Total assets
2023
301.6 bn
2024
327.4 bn
2025
317.2 bn

esef· 07 Apr 2026verified

Total liabilities
2023
292.0 bn
2024
318.1 bn
2025
307.7 bn

esef· 07 Apr 2026verified

Equity
2023
9.6 bn
2024
9.3 bn
2025
9.5 bn

esef· 07 Apr 2026verified

Cash flow · EUR

Operating cash flow
2023
864.0 m
2024
762.0 m
2025
434.0 m

esef· 07 Apr 2026verified

Capex
2023
65.0 m
2024
51.0 m
2025
41.0 m

esef· 07 Apr 2026verified

Free cash flow
2023
799.0 m ≈
2024
711.0 m ≈
2025
393.0 m ≈

esef· 07 Apr 2026derived

Investing cash flow
2023
-2.0 bn
2024
300.0 m
2025
1.0 bn

esef· 07 Apr 2026verified

Financing cash flow
2023
-3.2 bn
2024
-1.8 bn
2025
-2.0 bn

esef· 07 Apr 2026verified

Dividends paid
2023
494.0 m
2024
521.0 m
2025
596.0 m

esef· 07 Apr 2026verified

Share repurchases
2023
1.1 bn
2024
925.0 m
2025
549.0 m

esef· 07 Apr 2026verified

Computed indicators

Growth

Revenue growth (YoY)
unavailable
input data missing
Revenue CAGR 3Y
unavailable
input data missing
Revenue CAGR 5Y
unavailable
input data missing
EBIT growth (YoY)
unavailable
input data missing
Net income growth (YoY)
42.0%
computed by olivLawFY 2025
Net income CAGR 3Y
unavailable
the base of the ratio is not positive
Net income CAGR 5Y
unavailable
input data missing
EPS growth (YoY)
unavailable
input data missing
EPS CAGR 3Y
unavailable
input data missing
EPS CAGR 5Y
unavailable
input data missing
FCF growth (YoY)
-44.7%
computed by olivLawFY 2025

Profitability

Gross margin
unavailable
input data missing
EBITDA margin
unavailable
input data missing
EBIT margin
unavailable
input data missing
Net margin
unavailable
input data missing
FCF margin
unavailable
input data missing

Returns

ROE
10.5%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
ROA
0.3%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
ROIC
unavailable
input data missing
ROCE
unavailable
input data missing
Payout ratio (EPS)
unavailable
input data missing
Payout ratio (FCF)
151.7%
computed by olivLawFY 2025

Balance sheet

Net debt
unavailable
input data missing
Net debt / EBITDA
unavailable
input data missing
Debt / equity
unavailable
input data missing
Interest coverage
unavailable
input data missing

Liquidity

Current ratio
unavailable
input data missing
Quick ratio
unavailable
input data missing
Cash ratio
unavailable
input data missing

Cash

Operating cash flow
434.0 m EUR
computed by olivLawFY 2025
Capital expenditure
41.0 m EUR
computed by olivLawFY 2025
Free cash flow
393.0 m EUR
computed by olivLawFY 2025
FCF conversion
40.2%
computed by olivLawFY 2025
Cash conversion
unavailable
input data missing

Efficiency

Days sales outstanding
unavailable
input data missing
Days inventory outstanding
unavailable
input data missing
Days payables outstanding
unavailable
input data missing
Cash conversion cycle
unavailable
input data missing

Market and valuation

Market capitalisation
unavailable
input data missing
Enterprise value
unavailable
input data missing
Market cap / net income TTM
unavailable
input data missing
P/E (TTM)
unavailable
input data missing
Earnings yield
unavailable
input data missing
P/B
unavailable
input data missing
P/S
unavailable
input data missing
EV/EBITDA
unavailable
input data missing
EV/EBIT
unavailable
input data missing
EV/Sales
unavailable
input data missing
P/FCF
unavailable
input data missing
FCF yield
unavailable
input data missing
Dividend yield
unavailable
input data missing
Shareholder yield (distributions)
unavailable
input data missing

1 indicators that do not apply to the sector.

Valuation

olivLaw classification

Insufficient data
What is missing
  • indicators available: 2 of at least 6
  • score weight coverage: 10.4% of at least 60%
  • valuation methods computed: 0 of at least 1

A scoring methodology on indicators and valuation, not investment advice.

Closing price

7.63 EUR

05 Nov 2026Source: olivLaw, closing series

Market cap: unavailable

Key indicators

Market capitalisation
unavailable
input data missing
P/E (TTM)
unavailable
input data missing
P/B
unavailable
input data missing
EV/EBITDA
unavailable
input data missing
ROE
10.5%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
Net margin
unavailable
input data missing
Revenue growth (YoY)
unavailable
input data missing
Dividend yield
unavailable
input data missing

Coverage and freshness

14/37 reporting lines present
Latest full fiscal year: 2025
Latest reported period: 31 Dec 2025
Latest balance sheet date: 31 Dec 2025
Source: esefpublished 07 Apr 2026
verified 54

Score by group

10% · Insufficient data

Estimated value range

unavailable — no valuation method could be computed

Valuation assumptions are editorial choices, not measured; beta is not measured.

Valuation methods

  • DCF (discounted cash flow)unavailable · input data missing
  • Peers: EV/EBITDAunavailable · net debt missing: EV cannot be bridged to equity (missing debt is not zero)
  • Peers: P/Eunavailable · input data missing
  • Dividend discount (DDM)unavailable · input data missing

no valuation method could be computed

Assumptions (illustrative, editorial)

Risk-free rate
3.0%
Equity risk premium
5.5%
Beta (default)
1.00
Cost of equity
8.5%
Terminal growth
2.0%

Factor scorecard

Insufficient data

Minimum-evidence gate: indicators available: 2 of at least 6; score weight coverage: 10.4% of at least 60%; valuation methods computed: 0 of at least 1

FactorValueScoreWeight used
ROIC · Qualityunavailableunavailable—
Net margin · Qualityunavailableunavailable—
FCF conversion · Quality40.2%15 (on a fixed band)60%
Revenue CAGR 3Y · Growthunavailableunavailable—
EPS CAGR 3Y · Growthunavailableunavailable—
Net debt / EBITDA · Balance sheetunavailableunavailable—
Interest coverage · Balance sheetunavailableunavailable—
Current ratio · Balance sheetunavailableunavailable—
P/E (TTM) · Valuationunavailableunavailable—
EV/EBITDA · Valuationunavailableunavailable—
FCF yield · Valuationunavailableunavailable—
Shareholder yield (distributions) · Returnsunavailableunavailable—
Payout ratio (FCF) · Returns151.7%0 (on a fixed band)40%

Factors without a value were dropped; the remaining weights were renormalised.

Score groups

  • Balance sheet· partialunavailable · 0/3 factors with a value
  • Growth· partialunavailable · 0/2 factors with a value
  • Quality· partial15/100 · 1/3 factors with a value
  • Returns· partial0/100 · 1/2 factors with a value
  • Valuation· partialunavailable · 0/3 factors with a value

A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.

Memo

Aegon Ltd. (AGN.AS). Latest full fiscal year: 2025; data up to 2025-12-31.

Figures computed from the financial statements: ROE 10.5%.

Valuation cannot be computed from the available data.

Insufficient data for a verdict (indicators available: 2 of at least 6; score weight coverage: 10.4% of at least 60%; valuation methods computed: 0 of at least 1).

Text generated deterministically from the figures shown; no language model. Not investment advice.

What supports the thesis

No signal among the computed factors. That is not an absence of risk: factors without data were not assessed, and business risks (margins, inventory, demand) are in the source-based analysis.

What contradicts it

  • FCF conversion: 40.2%
  • Payout ratio (FCF): 151.7%

Not assessed (insufficient data or a ratio without meaning): ROIC, Net margin, Revenue CAGR 3Y, EPS CAGR 3Y, Net debt / EBITDA, Interest coverage, Current ratio, P/E (TTM), EV/EBITDA, FCF yield, Shareholder yield (distributions).

Versus the vertical median

Listed companies from Netherlands · same country · compared with 40 companies

Multiples and returns vs the median

P/E
—
vertical median 18.6x
EV/EBITDA
—
vertical median 9.9x
P/S
—
vertical median 0.8x
P/B
—
vertical median 2.1x
ROE
10.5%
vertical median 5.1%
above median (+106.5%)
Net margin
—
vertical median 2.2%
EBIT margin
—
vertical median 4.2%
Revenue YoY
—
vertical median 3.1%
Net debt/EBITDA
—
vertical median 0.1x
Dividend yield
—
vertical median 2.6%

Companies in the vertical

Market capP/EROENet marginRevenue YoY1A / 3A
ASML.ASASML Holding N.V.485.6 bn47.644.2%31.3%+15.6%+38% / +101%
DSFIR.ASDSM-Firmenich AG33.7 bn120.51.2%2.2%+20.4%+60% / +30%
AD.ASKoninklijke Ahold Delhaize N.V.31.2 bn13.915.3%2.5%+3.4%−3% / +30%
ASM.ASASM International N.V.31.2 bn43.318.7%22.8%+8.2%+34% / +35%
ADYEN.ASAdyen N.V.28.1 bn26.622.3%40.1%+18.9%−33% / −17%
HAL.ASHAL Trust15.5 bn9.710.5%12.8%+1.2%+22% / +47%
EXO.ASExor N.V.15.0 bn—-10.6%—−100.0%+1% / −18%
BESI.ASBE Semiconductor Industries N.V.11.2 bn84.928.7%22.3%−2.7%+8% / +10%
AKZA.ASAkzo Nobel N.V.10.7 bn17.013.8%6.3%−5.2%+12% / −11%
AALB.ASAalberts N.V.4.5 bn25.47.2%5.7%−5.3%+48% / +13%
ARCAD.ASArcadis N.V.4.2 bn20.218.3%4.3%−2.4%+24% / +2%
BNJ.ASBanijay Group N.V.3.4 bn13.8343.8%5.1%+1.6%−11% / −8%
BAMNB.ASKoninklijke BAM Groep N.V.3.3 bn41.89.1%1.3%+2.9%+47% / +400%
BFIT.ASBasic-Fit N.V.2.0 bn138.23.6%1.0%+16.9%+7% / +16%
HAVAS.ASHavas N.V.1.8 bn9.610.2%6.5%+1.7%+26% / unavailable
CRBN.ASCorbion N.V.1.6 bn8.327.3%14.9%+1.9%+40% / +55%
ECMPA.ASEurocommercial Properties N.V.1.4 bn11.25.9%45.4%+4.2%−4% / +19%
FUR.ASFugro N.V.985.3 m—-1.5%-1.1%−18.8%−0% / −49%
ACOMO.ASAcomo N.V.685.9 m15.210.7%3.3%+7.6%−3% / +37%
FAST.ASFastned B.V.663.0 m—-28.2%-21.7%+66.1%+60% / +25%
FFARM.ASForFarmers N.V.479.4 m9.614.5%1.6%+14.8%+22% / +123%
BRNL.ASBrunel International N.V.383.2 m125.51.0%0.3%−10.8%−6% / −29%
ENVI.ASEnvipco Holding N.V.224.1 m—-12.7%-11.9%−20.8%−25% / +47%
ALFEN.ASAlfen N.V.219.8 m—-0.1%-0.0%−10.7%−4% / −78%
CMCOM.ASCM.com N.V.192.5 m—-22.2%-1.5%−5.4%+23% / −30%

1- and 3-year price returns: for AGN.AS from daily closes (the same as the performance table), for the other companies from month-end closes.

olivLaw engine forecast

The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.

The engine has no published run for this company yet.

Valuation scenarios (editable assumptions)

Illustrative scenarios

Scenarios are not available. input data missing

AI analysis

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

In brief

Aegon Ltd. is an international group in life insurance, retirement and asset management, with its main operations in the United States through Transamerica. The company is moving its head office and legal seat to the US and aims to become a leading US life insurance and retirement group, which makes its profile relevant during this transition. Operating result for 2025 was EUR 1.7 billion.

SWOT

Strengths

  • Transamerica holds a strong position in the US life insurance and retirement market, supported by a large affiliated agent network.
  • Cash generation is supported by a rising operating result and solid operating capital generation.
  • A high ESG rating and a balance sheet described by management as strong support investor confidence.

Weaknesses

  • Heavy dependence on one main segment, Transamerica, which accounts for most of operations.
  • Inherited legacy Financial Assets carry volatility risks that the company is trying to reduce.
  • The simultaneous move of the head office and the switch to US GAAP demand substantial operational resources.

Opportunities

  • Growth in retirement and protection products for middle-income American families.
  • Expanding affiliated partnerships, including one with a Canadian insurer, could bring new clients.
  • If the Aegon UK review leads to a transaction, the company could redirect capital to growth activities.

Threats

  • Difficulties in executing the head office relocation could divert management attention from strategy.
  • A high-interest, persistent-inflation environment may affect investment returns and product demand.
  • Strong competition in the US and Asia could limit margin expansion.

Risks

  • Relocation execution riskmedium

    Moving the head office and legal seat to the US and renaming the group are complex operations. If the transition is delayed, costs could rise.

  • Reporting riskmedium

    The switch to US GAAP and reduced reporting frequency may make it harder for investors to track performance during the transition period.

  • Market and interest rate riskhigh

    Investment income depends on interest rates and financial markets. Sudden changes could affect results.

  • Joint venture riskmedium

    Many international activities run through partnerships with banks and other insurers, creating dependence on local partners.

  • Regulatory riskmedium

    Insurance activity is subject to strict regulation, and changes to the framework could alter capital requirements.

Investment thesis

What would need to be true (bull case)

  • If Transamerica sustains its growth and successfully reduces legacy Financial Assets, the group's risk profile could become more predictable.
  • Capital generation and the share buyback program show the company's capacity to return capital to shareholders.
  • Expansion of the agent network and partnerships could support growth in premium income.

What would break the thesis

  • The relocation could carry costs and execution risks that delay the expected strategic benefits.
  • Dependence on Transamerica leaves the group exposed to changes in the US market.
  • A high-interest-rate environment could weigh on returns and demand for savings and retirement products.

What to watch

  • Half-year results and progress of the head office relocation2026
  • Decision on the possible sale of Aegon UK2026
  • First report under US GAAP2027
  • Execution of the EUR 400 million share buyback program2026

Products, market & competition

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

The business

Aegon has fully owned businesses in the Americas and the United Kingdom, a global asset manager, and a life insurer serving affluent clients mainly in Asia. The company also has insurance joint ventures in Spain and Portugal, China and Brazil, and asset management partnerships in France and China. Revenue comes from insurance premiums, investment returns, fees and commissions. According to the 2025 annual report, Transamerica represents approximately 70% of operations.

In the Americas, Transamerica provides life insurance, retirement and investment solutions, while the affiliated World Financial Group network, with over 95,000 licensed agents, distributes products in the United States and Canada. The company is growing its direct and affiliated distribution to engage more directly with customers.

Financially, at year-end 2025 the company reported a rising operating result and operating capital generation of EUR 1.3 billion before holding and funding expenses. In 2025 Aegon sold part of its a.s.r. stake, reducing it to approximately 24%, and it announced a EUR 400 million share buyback program for 2026.

Segments

Americas

The American segment, including Transamerica and World Financial Group, is the main growth engine of the group. Transamerica is organized into four segments: Distribution, Savings & Investments, Protection Solutions and Financial Assets.

United Kingdom

Aegon UK aims to become a leading digital savings and retirement platform for employers and advisors. The company has announced a strategic review of this business, which includes a potential divestment.

Aegon International

The international segment covers life insurance for high-net-worth clients in Asia, as well as joint ventures in Spain and Portugal, Brazil and China. The company says it will keep investing in the profitable growth of these businesses.

Market context

Aegon operates in life insurance, retirement and asset management, markets where revenue depends on premiums, investment returns and fees. The company focuses on a few markets it considers the most promising, from the United States to Brazil and Asia.

Shifting the centre of gravity to the US places the group in a very large but competitive retirement and life insurance market. The company says it will report under US GAAP from full-year 2027 results, which could make its figures more comparable with US peers.

Trends

  • Relocation of head office to the USmixed

    Aegon has decided to move its head office and legal seat to the United States and to be renamed Transamerica Inc. on completion of the transition. The company hopes this will make the group more efficient and easier to understand, provided the operational transition is executed well.

  • Move to US GAAPmixed

    From 2027 the company will report under US GAAP and move to half-year reporting, stopping trading updates in 2026 and 2027. This could improve comparability with US peers but requires considerable operational effort.

  • Reduction of Financial Assetstailwind

    The company aims to reduce capital employed in its legacy Financial Assets lines and related risks, including through a reinsurance transaction. If the reduction succeeds, Transamerica's risk profile could become more stable.

  • Inflation and interest rate pressureheadwind

    The company cited a challenging environment of higher inflation, elevated interest rates and global uncertainty. These conditions can affect investment returns and client behaviour, but may also create opportunities for retirement products.

Competitive position

In the US market, Transamerica competes with other life and retirement insurers offering annuities, life cover and investment solutions. In Asia and through affiliated distribution, the group faces local and regional players, and its advantage lies in the World Financial Group network and bank partnerships.

In asset management, Aegon Asset Management competes with global investment houses, while in European pensions the group is compared with insurers operating in the United Kingdom and the Netherlands. The switch to US GAAP could make comparison with American peers more direct.

  • MetLifeMET

    Life and retirement insurer with significant US activity, a direct competitor of Transamerica in protection and retirement.

  • Prudential FinancialPRU

    American life and retirement insurer active in both retail and asset management.

  • Lincoln NationalLNC

    American life and retirement insurance group competing in savings, investment and retirement in the US.

  • Manulife

    Canadian life insurer active in Asia and Canada, named in the source as a partner in the expansion of WFG Canada.

News & filings

Figures computed by olivLaw from ESEF annual reports and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.